KCLAVIS Investment is a venture capital firm that is focused on asset management and investment advisory services.
Phone: +82 02-2070-3800
10, Gukjegeumyung-ro, Yeongdeungpo-gu
Three IFC 31F
Seoul, 07326
South Korea
Date | Company | Round | Amount | Co-investors |
---|---|---|---|---|
2020-12-28 | Bertis | Unattributed VC | $14.08M | BNH Investment, Focus Asset Management, Meritz Securities, NH Investment & Securities, Premier Partners, and Smilegate Investment |
2020-09-15 | AZTherapies | Series C - II | $11.2M | Axiom Associates, DEFTA Partners, DRADS Capital, Duopharma Biotech, ID Fund, Nextrans, SpinnAker Capital, and Wexford Capital |
2020-06-08 | ICONLOOP | Bridge | $5M | Danal Co., K-Growth, KIWOOM Investment, Korea Asset Investment Securities Co., Pathfinder H, and TS Investment |
2020-05-29 | GI Cell | Series A | $21.81M | AJU IB Investment, DAYLI Partners, and SL Investment |
2020-04-06 | Amyloid Solution | Series B | $14.82M | Korea Development Bank, TS Investment, and Yuhan |